BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 7030708)

  • 1. Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.
    Jackson JE; Bressler R
    Drugs; 1981 Oct; 22(4):295-320. PubMed ID: 7030708
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral hypoglycaemic drugs: clinical pharmacology and therapeutic use.
    Stowers JM; Borthwick LJ
    Drugs; 1977 Jul; 14(1):41-56. PubMed ID: 328260
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with glipizide in the treatment of mostly complicated diabetes.
    Masbernard A; Giudicelli C; Massey J
    Diabetologia; 1973 Sep; ():356-63. PubMed ID: 4772981
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of hypoglycemia with antihypertensive medication.
    Gambassi G; Carbonin P; Bernabei R
    JAMA; 1997 Nov; 278(19):1569-70; author reply 1570-1. PubMed ID: 9370497
    [No Abstract]   [Full Text] [Related]  

  • 5. Actual problems of the hypoglycaemic sulfonylureas.
    Káldor A
    Ther Hung; 1977; 25(2):47-50. PubMed ID: 898117
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oral antidiabetics].
    Bäbler M
    Schweiz Rundsch Med Prax; 1972 Feb; 61(8):242-6. PubMed ID: 4659095
    [No Abstract]   [Full Text] [Related]  

  • 7. Sulphonylurea therapy and hypothyroidism.
    Prince RL; Worth GK; Shenfield GM
    Practitioner; 1980 Dec; 224(1350):1287-9. PubMed ID: 7220451
    [No Abstract]   [Full Text] [Related]  

  • 8. Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases.
    Emanueli A; Molari E; Pirola LC; Caputo G
    Arzneimittelforschung; 1972 Nov; 22(11):1881-5. PubMed ID: 4267009
    [No Abstract]   [Full Text] [Related]  

  • 9. Undesired effects of the sulphonylurea drugs.
    Paice BJ; Paterson KR; Lawson DH
    Adverse Drug React Acute Poisoning Rev; 1985; 4(1):23-36. PubMed ID: 3890480
    [No Abstract]   [Full Text] [Related]  

  • 10. [Oral hypoglycaemic agents and cardiovascular deaths in diabetes].
    Drury MI; Timoney FJ
    Acta Diabetol Lat; 1972; 9(4):645-50. PubMed ID: 4657695
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin and oral hypoglycaemic agents. II. Clinical and therapeutic aspects.
    Breidahl HD; Ennis GC; Martin FI; Stawell JR; Taft P
    Drugs; 1972; 3(3):204-26. PubMed ID: 4561637
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral hypoglycaemic agents.
    Borthwick LJ; Stowers JM
    Practitioner; 1979 Mar; 222(1329):358-66. PubMed ID: 450836
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: Oral therapy in diabetes mellitus.
    Scoville AB
    South Med J; 1974 Jun; 67(6):635-8. PubMed ID: 4208385
    [No Abstract]   [Full Text] [Related]  

  • 14. Which sulphonylurea in diabetes mellitus?
    Drug Ther Bull; 1981 Jun; 19(13):49-51. PubMed ID: 7249943
    [No Abstract]   [Full Text] [Related]  

  • 15. ACE inhibitors and hypoglycaemia.
    Feher MD; Amiel S
    Lancet; 1995 Jul; 346(8967):125-6; author reply 126-7. PubMed ID: 7603199
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus].
    Ninni M; Castelletta L
    Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypoglycemic complications of oral drug therapy of diabetes mellitus. 21 cases].
    De Vigan C; Delporte MP; Thomas M; Perrault M
    Nouv Presse Med; 1976 Apr; 5(14):906-10. PubMed ID: 818620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glipizide, a new sulfonylurea in the treatment of diabetes mellitus].
    Villaseñor A
    Prensa Med Mex; 1973; 38(5):211-4. PubMed ID: 4782089
    [No Abstract]   [Full Text] [Related]  

  • 19. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus.
    Fövényi J
    Ther Hung; 1971; 19(2):43-8. PubMed ID: 5172874
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
    Vexiau P; Mavros P; Krishnarajah G; Lyu R; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():16-24. PubMed ID: 18435670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.